HINJ Statement on the Medical Device Excise Tax Repeal
HINJ President and Chief Executive Officer Dean J. Paranicas has issued the following statement about the full repeal of the medical device excise tax: “Patients, health care providers and the nearly 24,000 people who work for the medical technology sector in New Jersey will benefit from the decision by Congress to fully repeal the medical […]
HINJ Honors Pioneering Genetics Researcher Jay Tischfield of Rutgers
HINJ honored Prof. Jay A. Tischfield of Rutgers University–New Brunswick today (Dec. 9, 2019) “in recognition of innovative and creative leadership in genetics research, scholarship and commercial collaborations.” Tischfield, who is CEO, founder and scientific director of RUCDR Infinite Biologics and the Duncan and Nancy MacMillan Distinguished Professor of Genetics at Rutgers, received the 2019 […]
Booker’s Bill to Curb Drug Prices Would Kill Innovation – and N.J. Jobs, Trade Group Says (NJ.com)
For the first time in human history, we have cured hepatitis C – the days of liver transplants and life-long treatments are fast disappearing. We now have a simple vaccine that prevents cervical cancer, something unheard of only a few short years ago. HIV/AIDS has become a chronic, manageable condition instead of the death sentence […]
HINJ Presents Honorable Bob Franks Public Service Award to Joan Quigley
On Nov. 12, HINJ presented the 2019 Honorable Bob Franks Public Service Award to Joan Quigley, President/CEO of North Hudson Community Action Corporation (NHCAC). She was honored for her 45 years of public service, principally her dedicated leadership of NHCAC, which is one of New Jersey’s leading Federally Qualified Health Centers. She also was recognized […]
Federal Law Must Be Modernized to Foster Value-Based Payment in Health Care
All across New Jersey, leaders in health care, the biopharmaceutical and medical technology industries, associated industries and our state’s academic health care community are talking about the move to value-based payment for health care services. The Affordable Care Act, which expanded access to health care coverage, also initiated fundamental, positive changes in how health care […]
HINJ Statement on Health Care Proposal from Sen. Booker
New Brunswick, Nov. 15, 2019 — HINJ President and Chief Executive Officer Dean J. Paranicas today issued the following statement about the new health care proposal from Sen. Cory Booker (D-N.J.). “Intellectual property is the very lifeblood of American innovation – whether it is created in New Jersey, Silicon Valley, MIT or the Pentagon, or […]
New Jersey’s Economy and Medical Innovation Threatened by Speaker Pelosi’s Drug-Pricing Proposal
Asbury Park Press – Your Turn By Guest Columnist Dean J. Paranicas, President and Chief Executive Officer, HealthCare Institute of New Jersey (HINJ) House Speaker Nancy Pelosi is pushing a radical proposal on health care (H.R. 3) that would gut medical innovation and pose the danger of decimating New Jersey’s workforce and economy. While her […]
HINJ Presents Recognition Award to New Jersey STEM Pathways Network
HINJ Board of Trustees Chair Alex Kelly, who is executive vice president, Corporate Affairs, Allergan, presented the 2019 Award for Excellence in STEM Education to the New Jersey STEM Pathways Network at its quarterly meeting on Sept. 26 in Monroe Twp. HINJ President and CEO Dean J. Paranicas made opening remarks and introduced Mr. Kelly. […]
Repeal the Medical Device Excise Tax Before it Causes More Harm
HINJ joined MDMA, AdvaMed, MITA and a broad coalition of medical innovators, physician inventors, patient groups in sending a letter to Congress Sept. 24 urging them to permanently repeal the medical device excise tax to the innovation ecosystem. While the tax was in place from 2013 through 2015, thousands of good paying jobs were lost, […]
HINJ Statement on H.R. 3, the Drug Pricing Proposal in Congress
This legislation poses the danger of decimating New Jersey’s workforce and economy. New Brunswick, Sept. 20, 2019 ― HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas today issued the following statement about H.R. 3: “The HealthCare Institute of New Jersey (HINJ) has very serious concerns with H.R. 3, the […]